EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical trials. The study is…
Not a fan of AI? Tired of every app and device adding some sort of AI functionality?
Then Firefox has some good news for you. The popular web browser, which is run by the…










